Cencora Inc (COR)

Currency in USD
358.44
-0.59(-0.16%)
Real-time Data·

COR Earnings

Latest Release
Nov 04, 2026
EPS / Forecast
4.66 / 4.57
Revenue / Forecast
88.4B / 87.97B
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/12--/4.56--/90.30B----Free Sign Up
2026/094.66/4.5788.40B/87.97B+1.97%+0.49%Free Sign Up
2026/064.48/4.3584.80B/84.36B+2.99%+0.52%Free Sign Up
2026/034.75/4.8378.40B/80.97B-1.66%-3.17%Free Sign Up
2025/124.08/4.0485.90B/86.02B+0.99%-0.14%Free Sign Up
2025/093.84/3.7983.70B/83.46B+1.32%+0.29%Free Sign Up
2025/064.00/3.8480.66B/80.31B+4.17%+0.44%Free Sign Up
2025/034.42/4.0675.50B/75.14B+8.87%+0.48%Free Sign Up
2024/123.73/3.4981.50B/78.22B+6.88%+4.19%Free Sign Up
2024/093.34/3.2279.10B/77.59B+3.73%+1.95%Free Sign Up

All numbers in USD

Cencora Inc Earnings Call Summary for Q4/2026

  • Cencora reported Q4 adjusted EPS of $4.66, beating estimates of $4.57, with revenue rising 6% to $88.4B driven by specialty pharmaceutical demand.
  • Full-year fiscal 2026 adjusted EPS grew 12% to $17.97 with 14% operating income growth; company raised dividend 10%, marking 22nd consecutive increase.
  • FY2027 guidance projects 3-5% revenue growth and adjusted EPS of $19.40-$19.75, with specialty segment expected to grow 18-21% in operating income.
  • Shares rose 0.66% to $342.75 pre-market; company plans $1.25B in buybacks and $3.5B adjusted free cash flow despite divestiture headwinds.
  • Management emphasized strategic shift toward specialty biologics, now over half of U.S. pharma spending, with 100+ new products expected through 2030.
Last Updated: 2026-11-04, 10:14 a/m
Read Full Transcript

FAQ

What Is Cencora Inc's Earnings Per Share (TTM)?

The Cencora Inc EPS (TTM) is 18.03.

When Is The Next Cencora Inc Earnings Date?

Cencora Inc will release its next earnings report on Feb 03, 2027.

What Is Cencora Inc’s Revenue Forecasts For Upcoming Quarters?

Cencora Inc’s revenue forecast is 90.30B.

How Did Cencora Inc React to the Company's Latest Earnings Report?

Cencora Inc reported a +1.97% EPS surprise and a +0.49% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -0.24%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.